
If you've noticed something feels different and you're in ketamine-assisted therapy, what you're experiencing is almost certainly transient and expected.
Ketamine blocks the NMDA receptor subset of glutamate receptors. The hippocampus — the brain region most responsible for forming new memories — relies heavily on NMDA receptors for that work, which is why ketamine has measurable acute effects on memory formation during a session.
But the same NMDA blockade is what produces ketamine's antidepressant effect: it triggers downstream BDNF release, AMPA receptor activation, and neuroplastic changes that lift depressive symptoms within hours. The acute memory effect and the antidepressant effect come from the same mechanism, and both are reversible.
For more on how ketamine works at the molecular level, see how does ketamine work.
What patients commonly report:
These typically resolve within hours. Most patients can return to normal daily activities the same day or the next morning, though driving and other safety-sensitive tasks should wait at least 4–6 hours.
The body of research on ketamine and memory points consistently in one direction: acute effects during dosing, with full recovery between sessions in clinically-supervised use.
In supervised clinical use: no.
In chronic recreational abuse: there are documented cognitive deficits — particularly in working memory and attention — that improve substantially with abstinence but may take months to fully recover. The dose-frequency thresholds for those effects are much higher than therapeutic protocols (which typically dose every 1–4 weeks).
If you're in a clinical program and you're worried, talk to your provider. The most useful framing is: ketamine briefly turns the volume down on memory formation during a session, then turns it back up afterward. The volume knob is intact.
Practical things patients can do:
If memory or concentration problems persist beyond a few days after a session, or get worse over a treatment course rather than better, raise it with your provider — the protocol may need adjustment.
The acute effects typically resolve within 4–6 hours of dosing. Mild lingering brain fog can persist into the next day in some patients. Working and episodic memory return to baseline between sessions.
In supervised clinical use, no. Chronic high-frequency recreational abuse has been associated with bladder dysfunction and cognitive impairment, both of which improve with cessation. The exposure pattern in therapy is dramatically different from problematic recreational use.
You can soften them — sleep, hydration, journaling, and avoiding cognitively demanding tasks for several hours after a session all help. The effects themselves are an expected part of how ketamine works during dosing, not a side effect to eliminate.
Mild, transient effects during and right after a session are expected. If memory or concentration changes persist beyond a few days, worsen over a treatment course, or interfere with daily function, talk to your provider — protocols can be adjusted.
Current evidence supports the safety of intermittent ketamine therapy under medical supervision. The risks (bladder issues, cognitive effects, dependence) are tied to high-frequency, high-dose, unsupervised use — patterns clinical programs are designed to avoid.
"Reset" is a loose term. Ketamine triggers a window of enhanced neuroplasticity — increased BDNF, new synaptic connections — during which old depressive thought patterns become more changeable. It's better described as opening a window for change rather than wiping a slate clean.
Considering ketamine therapy? Isha Health offers physician-led at-home treatment with an 88.8% improvement rate. Check appointment availability.
88.8% of Isha Health patients with moderate-to-severe depression show measurable improvement
Based on 546 patients and 1,900+ validated assessments. See our clinical outcomes →
Stay informed on ketamine therapy
Research updates, clinical insights, and mental health resources — delivered to your inbox.